Loading...

We've got a brand new version of Simply Wall St! Try it out

Cannabis One Holdings

CNSX:CBIS
Snowflake Description

Flawless balance sheet and overvalued.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
CBIS
CNSX
CA$43M
Market Cap
  1. Home
  2. CA
  3. Pharmaceuticals & Biotech
Company description

Cannabis One Holdings Inc. focuses on providing management resources, and infrastructure and equipment for the production, cultivation, and dispensary operations of licensed cannabis businesses in the United States. The last earnings update was 38 days ago. More info.


Add to Portfolio Compare Print
  • Cannabis One Holdings has significant price volatility in the past 3 months.
CBIS Share Price and Events
7 Day Returns
0%
CNSX:CBIS
-0.2%
CA Pharmaceuticals
1.2%
CA Market
1 Year Returns
-
CNSX:CBIS
-45.8%
CA Pharmaceuticals
-0.4%
CA Market
CBIS Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Cannabis One Holdings (CBIS) 0% -14.6% -57.3% - - -
CA Pharmaceuticals -0.2% -1.8% -21.5% -45.8% 251% 334.4%
CA Market 1.2% 3.3% 0.8% -0.4% 7.4% 4.5%
1 Year Return vs Industry and Market
  • No trading data on CBIS.
  • No trading data on CBIS.
Price Volatility
Industry
5yr Volatility vs Market

CBIS Value

 Is Cannabis One Holdings undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Cannabis One Holdings. This is due to cash flow or dividend data being unavailable. The share price is CA$0.35.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Cannabis One Holdings's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Cannabis One Holdings's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
CNSX:CBIS PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in USD $-0.04
CNSX:CBIS Share Price ** CNSX (2019-09-19) in CAD CA$0.35
CNSX:CBIS Share Price converted to USD reporting currency Exchange rate (CAD/ USD) 0.754 $0.26
Canada Pharmaceuticals Industry PE Ratio Median Figure of 13 Publicly-Listed Pharmaceuticals Companies 18.72x
Canada Market PE Ratio Median Figure of 540 Publicly-Listed Companies 14.11x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Cannabis One Holdings.

CNSX:CBIS PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= CNSX:CBIS Share Price ÷ EPS (both in USD)

= 0.26 ÷ -0.04

-6.15x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Cannabis One Holdings is loss making, we can't compare its value to the CA Pharmaceuticals industry average.
  • Cannabis One Holdings is loss making, we can't compare the value of its earnings to the Canada market.
Price based on expected Growth
Does Cannabis One Holdings's expected growth come at a high price?
Raw Data
CNSX:CBIS PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -6.15x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
Canada Pharmaceuticals Industry PEG Ratio Median Figure of 7 Publicly-Listed Pharmaceuticals Companies 1.57x
Canada Market PEG Ratio Median Figure of 246 Publicly-Listed Companies 0.95x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Cannabis One Holdings, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Cannabis One Holdings's assets?
Raw Data
CNSX:CBIS PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in USD $0.15
CNSX:CBIS Share Price * CNSX (2019-09-19) in CAD CA$0.35
CNSX:CBIS Share Price converted to USD reporting currency Exchange rate (CAD/ USD) 0.754 $0.26
Canada Pharmaceuticals Industry PB Ratio Median Figure of 151 Publicly-Listed Pharmaceuticals Companies 2.32x
Canada Market PB Ratio Median Figure of 2,454 Publicly-Listed Companies 1.44x
CNSX:CBIS PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= CNSX:CBIS Share Price ÷ Book Value per Share (both in USD)

= 0.26 ÷ 0.15

1.76x

* Primary Listing of Cannabis One Holdings.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Cannabis One Holdings is good value based on assets compared to the CA Pharmaceuticals industry average.
X
Value checks
We assess Cannabis One Holdings's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Pharmaceuticals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Pharmaceuticals industry average (and greater than 0)? (1 check)
  5. Cannabis One Holdings has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

CBIS Future Performance

 How is Cannabis One Holdings expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Cannabis One Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
110.6%
Expected Pharmaceuticals industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Cannabis One Holdings expected to grow at an attractive rate?
  • Unable to compare Cannabis One Holdings's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Cannabis One Holdings's earnings growth to the Canada market average as no estimate data is available.
  • Unable to compare Cannabis One Holdings's revenue growth to the Canada market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
CNSX:CBIS Future Growth Rates Data Sources
Data Point Source Value (per year)
Canada Pharmaceuticals Industry Earnings Growth Rate Market Cap Weighted Average 110.6%
Canada Pharmaceuticals Industry Revenue Growth Rate Market Cap Weighted Average 58.6%
Canada Market Earnings Growth Rate Market Cap Weighted Average 12.8%
Canada Market Revenue Growth Rate Market Cap Weighted Average 5.9%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
CNSX:CBIS Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (8 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
CNSX:CBIS Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2018-12-31 3 -2 -2
2018-09-30 2 -1 -1
2017-12-31 1 0 0
2016-12-31 0 0

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Cannabis One Holdings is high growth as no earnings estimate data is available.
  • Unable to determine if Cannabis One Holdings is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
CNSX:CBIS Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (8 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Cannabis One Holdings Company Filings, last reported 8 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:CBIS Past Financials Data
Date (Data in USD Millions) EPS *
2018-12-31 -0.04
2018-09-30 -0.15
2017-12-31 -0.01
2016-12-31 -0.03

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Cannabis One Holdings will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Examine Cannabis One Holdings's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  2. Cannabis One Holdings's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Pharmaceuticals & Biotech companies here
  3. Cannabis One Holdings's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Cannabis One Holdings's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Canada market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Canada market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Cannabis One Holdings has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

CBIS Past Performance

  How has Cannabis One Holdings performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Cannabis One Holdings's growth in the last year to its industry (Pharmaceuticals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Cannabis One Holdings does not make a profit and there is insufficient past data to establish if their 5 year on year earnings growth rate was positive.
  • Unable to compare Cannabis One Holdings's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Cannabis One Holdings's 1-year growth to the CA Pharmaceuticals industry average as it is not currently profitable.
Earnings and Revenue History
Cannabis One Holdings's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Cannabis One Holdings Company Filings, last reported 8 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:CBIS Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 2.71 -1.73 1.57
2018-09-30 1.81 -0.93 1.55
2017-12-31 0.93 -0.18 0.46
2016-12-31 -0.13 0.07

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Cannabis One Holdings has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Cannabis One Holdings has efficiently used its assets last year compared to the CA Pharmaceuticals industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Cannabis One Holdings improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Cannabis One Holdings's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Pharmaceuticals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Cannabis One Holdings has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

CBIS Health

 How is Cannabis One Holdings's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Cannabis One Holdings's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Cannabis One Holdings is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Cannabis One Holdings has no long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Cannabis One Holdings's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Cannabis One Holdings has no debt, it does not need to be covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Cannabis One Holdings Company Filings, last reported 8 months ago.

CNSX:CBIS Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 8.05 0.00 3.76
2018-09-30 2.98 0.30 0.07
2017-12-31 3.37 0.00 0.98
2016-12-31 2.29 0.00 0.53
  • Cannabis One Holdings has no debt.
  • Cannabis One Holdings currently has no debt however we can't compare to 5 years ago as we have no data for that period.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Cannabis One Holdings has sufficient cash runway for 1.1 years based on current free cash flow.
  • Cannabis One Holdings has sufficient cash runway for 1.8 years if free cash flow continues to grow at historical rates of 56.7% each year.
X
Financial health checks
We assess Cannabis One Holdings's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Cannabis One Holdings has a total score of 6/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

CBIS Dividends

 What is Cannabis One Holdings's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Cannabis One Holdings dividends.
If you bought CA$2,000 of Cannabis One Holdings shares you are expected to receive CA$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Cannabis One Holdings's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Cannabis One Holdings's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
CNSX:CBIS Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
North America Pharmaceuticals Industry Average Dividend Yield Market Cap Weighted Average of 10 Stocks 2.8%
Canada Market Average Dividend Yield Market Cap Weighted Average of 334 Stocks 3.5%
Canada Minimum Threshold Dividend Yield 10th Percentile 1.2%
Canada Bottom 25% Dividend Yield 25th Percentile 2%
Canada Top 25% Dividend Yield 75th Percentile 5.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Cannabis One Holdings has not reported any payouts.
  • Unable to verify if Cannabis One Holdings's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Cannabis One Holdings's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Cannabis One Holdings has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Cannabis One Holdings's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.2%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Cannabis One Holdings afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Cannabis One Holdings has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

CBIS Management

 What is the CEO of Cannabis One Holdings's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Jeffery Mascio
CEO Bio

Mr. Jeffery Allan Mascio serves as Chief Executive Officer & Director of Cannabis One Holdings Inc. formerly known as Bertram Capital Finance Inc since July 2019. He served as Chairman of the Board & President at Cannabis One Holdings Inc. until July 2019.

CEO Compensation
  • Insufficient data for Jeffery to compare compensation growth.
  • Insufficient data for Jeffery to establish whether their remuneration is reasonable compared to companies of similar size in Canada.
Management Team Tenure

Average tenure of the Cannabis One Holdings management team in years:

0.3
Average Tenure
  • The average tenure for the Cannabis One Holdings management team is less than 2 years, this suggests a new team.
Management Team

Jeffery Mascio

TITLE
CEO & Director

Josh Mann

TITLE
President & Director
TENURE
0.2 yrs

Theresa Mohan

TITLE
Interim Chief Financial Officer
TENURE
0.3 yrs

Anthony Segarra

TITLE
Interim Chief Operating Officer
TENURE
0.3 yrs

Darrick Payne

TITLE
VP of Compliance & Director

Ryan Atkins

TITLE
General Counsel
TENURE
0.3 yrs

Brad Harris

TITLE
VP of Retail Operations & Director
Board of Directors

Chris Fenn

TITLE
Chairman of the Board
TENURE
0.2 yrs

Jeffery Mascio

TITLE
CEO & Director

Josh Mann

TITLE
President & Director

Darrick Payne

TITLE
VP of Compliance & Director

Brad Harris

TITLE
VP of Retail Operations & Director

Frank Sur

TITLE
Director
AGE
39
TENURE
0.3 yrs
Who owns this company?
Recent Insider Trading
  • More shares have been bought than sold by Cannabis One Holdings individual insiders in the past 3 months, but not in substantial volumes.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (CA$) Value (CA$)
28. Aug 19 Buy Darrick Payne Individual 28. Aug 19 28. Aug 19 20,000 CA$0.37 CA$7,444
31. Jul 19 Buy Joshua Mann Individual 26. Jul 19 26. Jul 19 10,500 CA$0.47 CA$4,485
19. Jun 19 Buy Patrick Rinker Individual 17. Jun 19 17. Jun 19 5,000 CA$1.29 CA$6,434
12. Jun 19 Buy Patrick Rinker Individual 10. Jun 19 10. Jun 19 400 CA$1.46 CA$584
05. Jun 19 Buy Bradley Harris Individual 31. May 19 31. May 19 900 CA$1.42 CA$1,277
28. May 19 Buy Christopher Fenn Individual 01. Mar 19 13. May 19 6,700 CA$3.41 CA$21,395
27. May 19 Buy Wildhorse Capital Partners Inc Company 01. Mar 19 22. May 19 18,500 CA$3.73 CA$50,998
X
Management checks
We assess Cannabis One Holdings's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Cannabis One Holdings has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

CBIS News

Simply Wall St News

Is Cannabis One Holdings (CNSX:CBIS) Using Too Much Debt?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' It's only natural to consider a company's balance sheet when you examine how risky it is, since debt is often involved when a business collapses. … CNSX:CBIS Historical Debt, July 18th 2019 A Look At Cannabis One Holdings's Liabilities Zooming in on the latest balance sheet data, we can see that Cannabis One Holdings had liabilities of US$724.4k due within 12 months and no liabilities due beyond that. … This state of affairs indicates that Cannabis One Holdings's balance sheet looks quite solid, as its total liabilities are just about equal to its liquid assets.

Simply Wall St -

What Kind Of Shareholders Own Cannabis One Holdings Inc. (CNSX:CBIS)?

View our latest analysis for Cannabis One Holdings CNSX:CBIS Ownership Summary, May 9th 2019 What Does The Lack Of Institutional Ownership Tell Us About Cannabis One Holdings? … Insider Ownership Of Cannabis One Holdings The definition of an insider can differ slightly between different countries, but members of the board of directors always count. … Private Company Ownership We can see that Private Companies own 11%, of the shares on issue.

Simply Wall St -

CBIS Company Info

Description

Cannabis One Holdings Inc. focuses on providing management resources, and infrastructure and equipment for the production, cultivation, and dispensary operations of licensed cannabis businesses in the United States. It offers products under the Cannabis, INDVR, and INDVR Fire brand names. The company offers products through its dispensaries under the Joint name, as well as through other dispensary owners. Cannabis One Holdings Inc. is headquartered in Vancouver, Canada.

Details
Name: Cannabis One Holdings Inc.
CBIS
Exchange: CNSX
Founded:
CA$42,716,574
122,047,355
Website: http://www.cannabisone.life
Address: Cannabis One Holdings Inc.
700 West Pender Street,
Suite 610,
Vancouver,
British Columbia, V6C 1G8,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
CNSX CBIS Class A Subordinated Voting Shares Canadian National Stock Exchange CA CAD 26. Feb 2019
OTCPK CAAO.F Class A Subordinated Voting Shares Pink Sheets LLC US USD 26. Feb 2019
MUN 3YX Class A Subordinated Voting Shares Boerse Muenchen DE EUR 26. Feb 2019
Number of employees
Current staff
Staff numbers
0
Cannabis One Holdings employees.
Industry
Pharmaceuticals
Pharmaceuticals & Biotech
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/09/20 01:34
End of day share price update: 2019/09/19 00:00
Last earnings filing: 2019/08/13
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.